Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Design and Synthesis of Waterborne Polyurethanes.

Kang SY, Ji Z, Tseng LF, Turner SA, Villanueva DA, Johnson R, Albano A, Langer R.

Adv Mater. 2018 May;30(18):e1706237. doi: 10.1002/adma.201706237. Epub 2018 Mar 15.

PMID:
29543353
2.

Shape memory activation can affect cell seeding of shape memory polymer scaffolds designed for tissue engineering and regenerative medicine.

Wang J, Brasch ME, Baker RM, Tseng LF, Peña AN, Henderson JH.

J Mater Sci Mater Med. 2017 Aug 31;28(10):151. doi: 10.1007/s10856-017-5962-z.

PMID:
28861660
3.

Osteogenic Capacity of Human Adipose-Derived Stem Cells is Preserved Following Triggering of Shape Memory Scaffolds.

Tseng LF, Wang J, Baker RM, Wang G, Mather PT, Henderson JH.

Tissue Eng Part A. 2016 Aug;22(15-16):1026-35. doi: 10.1089/ten.TEA.2016.0095. Epub 2016 Aug 2.

PMID:
27401991
4.

Seroprevalence of antibodies against dengue virus among pregnant women in the Democratic Republic of Sao Tome and Principe.

Yen TY, Trovoada dos Santos Mde J, Tseng LF, Chang SF, Cheng CF, Carvalho AV, Shu PY, Lien JC, Tsai KH.

Acta Trop. 2016 Mar;155:58-62. doi: 10.1016/j.actatropica.2015.12.012. Epub 2015 Dec 29.

PMID:
26739653
5.

Self-deploying shape memory polymer scaffolds for grafting and stabilizing complex bone defects: A mouse femoral segmental defect study.

Baker RM, Tseng LF, Iannolo MT, Oest ME, Henderson JH.

Biomaterials. 2016 Jan;76:388-98. doi: 10.1016/j.biomaterials.2015.10.064. Epub 2015 Oct 28.

PMID:
26561935
6.

Association of Psychosocial Factors and Heart Rate Variability in Heart Failure Patients.

Kao CW, Tseng LF, Lin WS, Cheng SM.

West J Nurs Res. 2014 Jul;36(6):769-87. doi: 10.1177/0193945913505922. Epub 2013 Sep 26.

PMID:
24071790
7.

Shape-memory-actuated change in scaffold fiber alignment directs stem cell morphology.

Tseng LF, Mather PT, Henderson JH.

Acta Biomater. 2013 Nov;9(11):8790-801. doi: 10.1016/j.actbio.2013.06.043. Epub 2013 Jul 9.

PMID:
23851156
8.

Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats.

Chen SL, Tao PL, Chu CH, Chen SH, Wu HE, Tseng LF, Hong JS, Lu RB.

J Neuroimmune Pharmacol. 2012 Jun;7(2):444-53. doi: 10.1007/s11481-011-9337-9. Epub 2011 Dec 29.

9.

(+)-Morphine attenuates the (-)-morphine-produced tail-flick inhibition via the sigma-1 receptor in the mouse spinal cord.

Tseng LF, Hogan QH, Wu HE.

Life Sci. 2011 Dec 5;89(23-24):875-7. doi: 10.1016/j.lfs.2011.09.018. Epub 2011 Oct 2.

10.

[Nursing care of patients with implantable cardioverter defibrillators].

Kao CW, Tseng LF, Lin WH.

Hu Li Za Zhi. 2009 Oct;56(5):10-5. Review. Chinese.

PMID:
19760572
11.

Effect of relaxation-breathing training on anxiety and asthma signs/symptoms of children with moderate-to-severe asthma: a randomized controlled trial.

Chiang LC, Ma WF, Huang JL, Tseng LF, Hsueh KC.

Int J Nurs Stud. 2009 Aug;46(8):1061-70. doi: 10.1016/j.ijnurstu.2009.01.013. Epub 2009 Feb 26.

PMID:
19246041
12.

Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.

Chen SN, Hwang JF, Tseng LF, Lin CJ.

Ophthalmology. 2008 Dec;115(12):2229-34. doi: 10.1016/j.ophtha.2008.08.026.

PMID:
19041477
13.

Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.

Terashvili M, Tseng LF, Wu HE, Narayanan J, Hart LM, Falck JR, Pratt PF, Harder DR.

J Pharmacol Exp Ther. 2008 Aug;326(2):614-22. doi: 10.1124/jpet.108.136739. Epub 2008 May 20.

14.

(+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat.

Terashvili M, Wu HE, Schwasinger ET, Hung KC, Hong JS, Tseng LF.

Eur J Pharmacol. 2008 Jun 10;587(1-3):147-54. doi: 10.1016/j.ejphar.2008.03.020. Epub 2008 Mar 29.

15.

Rapid control of malaria by means of indoor residual spraying of alphacypermethrin in the Democratic Republic of São Tomé and Príncipe.

Tseng LF, Chang WC, Ferreira MC, Wu CH, Rampão HS, Lien JC.

Am J Trop Med Hyg. 2008 Feb;78(2):248-50.

PMID:
18256424
17.

Seroprevalence of Toxoplasma gondii infection among inhabitants in the Democratic Republic of Sao Tome and Principe.

Fan CK, Hung CC, Su KE, Chiou HY, Gil V, Ferreira Mda C, Tseng LF.

Trans R Soc Trop Med Hyg. 2007 Nov;101(11):1157-8. Epub 2007 Jul 2.

PMID:
17606284
19.

Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.

Sykes KT, White SR, Hurley RW, Mizoguchi H, Tseng LF, Hammond DL.

J Pharmacol Exp Ther. 2007 Aug;322(2):813-21. Epub 2007 May 9.

20.

dextro-Morphine attenuates the morphine-produced conditioned place preference via the sigma(1) receptor activation in the rat.

Wu HE, Schwasinger ET, Terashvili M, Tseng LF.

Eur J Pharmacol. 2007 May 21;562(3):221-6. Epub 2007 Feb 8.

21.

Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and Principe.

Hung CC, Fan CK, Su KE, Sung FC, Chiou HY, Gil V, da Conceicao dos Reis Ferreira M, de Carvalho JM, Cruz C, Lin YK, Tseng LF, Sao KY, Chang WC, Lan HS, Chou SH.

Trans R Soc Trop Med Hyg. 2007 Feb;101(2):134-9. Epub 2006 Nov 17.

PMID:
17113117
22.
23.
24.
25.

dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.

Wu HE, Sun HS, Terashivili M, Schwasinger E, Sora I, Hall FS, Uhl GR, Tseng LF.

Eur J Pharmacol. 2006 Feb 15;531(1-3):103-7. Epub 2006 Jan 30.

PMID:
16445907
26.

Seroprevalence of Toxoplasma gondii infection among pre-schoolchildren aged 1-5 years in the Democratic Republic of Sao Tome and Principe, Western Africa.

Fan CK, Hung CC, Su KE, Sung FC, Chiou HY, Gil V, da Conceicao dos Reis Ferreira M, de Carvalho JM, Cruz C, Lin YK, Tseng LF, Sao KY, Chang WC, Lan HS, Chou SH.

Trans R Soc Trop Med Hyg. 2006 May;100(5):446-9. Epub 2005 Nov 2.

PMID:
16260015
27.
28.

Antianalgesia: stereoselective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord.

Wu HE, Thompson J, Sun HS, Terashvili M, Tseng LF.

J Pharmacol Exp Ther. 2005 Sep;314(3):1101-8. Epub 2005 May 18.

29.

Differential mechanisms of antianalgesia induced by endomorphin-1 and endomorphin-2 in the ventral periaqueductal gray of the rat.

Terashvili M, Wu HE, Leitermann RJ, Sun HS, Clithero AD, Tseng LF.

J Pharmacol Exp Ther. 2005 Mar;312(3):1257-65. Epub 2004 Nov 12.

30.

Increased release of immunoreactive dynorphin A1-17 from the spinal cord after intrathecal treatment with endomorphin-2 in anesthetized rats.

Leitermann RJ, Terashvili M, Mizoguchi H, Wu HE, Chen F, Clithero A, Tseng LF.

Eur J Pharmacol. 2004 Nov 19;504(3):177-83.

PMID:
15541419
31.

Rational drug design and synthesis of a selective opioid receptor antagonist on the basis of the accessory site concept.

Fujii H, Narita M, Mizoguchi H, Hirokawa J, Kawai K, Tanaka T, Tseng LF, Nagase H.

Bioorg Med Chem Lett. 2004 Aug 16;14(16):4241-3.

PMID:
15261278
32.

Opposite conditioned place preference responses to endomorphin-1 and endomorphin-2 in the mouse.

Wu HE, MacDougall RS, Clithero AD, Leitermann RJ, Terashvili M, Tseng LF.

Neurosci Lett. 2004 Jul 29;365(3):157-61.

PMID:
15246539
34.

Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.

Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF.

J Pharmacol Exp Ther. 2004 Jul;310(1):240-6. Epub 2004 Mar 3.

35.

Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat.

Terashvili M, Wu HE, Leitermann RJ, Hung KC, Clithero AD, Schwasinger ET, Tseng LF.

J Pharmacol Exp Ther. 2004 May;309(2):816-24. Epub 2004 Jan 30.

36.

Region-dependent G-protein activation by kappa-opioid receptor agonists in the mouse brain.

Mizoguchi H, Leitermann RJ, Narita M, Nagase H, Suzuki T, Tseng LF.

Neurosci Lett. 2004 Feb 12;356(2):145-7.

PMID:
14746884
37.

Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.

Mizoguchi H, Wu HE, Narita M, Sora I, Hall SF, Uhl GR, Loh HH, Nagase H, Tseng LF.

J Pharmacol Sci. 2003 Dec;93(4):423-9.

39.

Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.

Narita M, Khotib J, Mizoguchi H, Suzuki M, Ozaki S, Yajima Y, Tseng LF, Suzuki T.

Eur J Neurosci. 2003 Nov;18(9):2498-504.

PMID:
14622150
40.

Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.

Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.

J Pharmacol Exp Ther. 2003 Dec;307(3):1135-41. Epub 2003 Oct 13.

41.

An opioid basis for early-phase isoflurane-induced hypotension in rats.

Ellenberger EA, Lucas HL, Russo JM, Mueller JL, Barrington PL, Tseng LF, Quock RM.

Life Sci. 2003 Oct 3;73(20):2591-602.

PMID:
12967683
42.
43.

Antinociceptive properties of oxymorphazole in the mouse.

Wu HE, Sun HS, Darpolar M, Dunn W 3rd, Tseng LF.

Eur J Pharmacol. 2003 Jul 25;473(2-3):143-8.

PMID:
12892831
44.

Involvement of beta-arrestin-2 in modulation of the spinal antinociception induced by mu-opioid receptor agonists in the mouse.

Ohsawa M, Mizoguchi H, Narita M, Nagase H, Dun NJ, Tseng LF.

Neurosci Lett. 2003 Jul 31;346(1-2):13-6.

PMID:
12850536
45.

Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.

Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.

J Pharmacol Exp Ther. 2003 Jul;306(1):394-400. Epub 2003 Apr 29.

46.

Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion.

Narita M, Mizuo K, Mizoguchi H, Sakata M, Narita M, Tseng LF, Suzuki T.

J Neurosci. 2003 Feb 1;23(3):1006-12.

47.

Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.

Mizoguchi H, Hung KC, Leitermann R, Narita M, Nagase H, Suzuki T, Tseng LF.

Eur J Pharmacol. 2003 Feb 7;461(1):35-9.

PMID:
12568913
48.

Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment.

Narita M, Suzuki M, Mizoguchi H, Narita M, Yajima Y, Sakurada S, Tseng LF, Suzuki T.

Neurosci Lett. 2003 Feb 27;338(2):103-6.

PMID:
12566163
49.

Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.

Mizoguchi H, Wu HE, Narita M, Loh HH, Nagase H, Tseng LF.

Neurosci Lett. 2002 Dec 25;335(2):91-4.

PMID:
12459506
50.

Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse.

Ohsawa M, Brailoiu GC, Shiraki M, Dun NJ, Paul K, Tseng LF.

Pain. 2002 Nov;100(1-2):27-34.

PMID:
12435456

Supplemental Content

Loading ...
Support Center